Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Treasury Shares (2016 - 2022)

ENDRA Life Sciences has reported Treasury Shares over the past 6 years, most recently at $121818.0 for Q4 2021.

  • Quarterly Treasury Shares fell 98.05% to $121818.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $121818.0 through Dec 2021, down 98.05% year-over-year, with the annual reading at $121818.0 for FY2021, 98.05% down from the prior year.
  • Treasury Shares was $121818.0 for Q4 2021 at ENDRA Life Sciences, down from $2.4 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $13.5 million in Q4 2019 and troughed at $121818.0 in Q4 2021.
  • The 5-year median for Treasury Shares is $2.6 million (2018), against an average of $4.4 million.
  • Year-over-year, Treasury Shares surged 1384.11% in 2017 and then tumbled 98.05% in 2021.
  • A 5-year view of Treasury Shares shows it stood at $2.3 million in 2017, then increased by 15.87% to $2.6 million in 2018, then surged by 413.58% to $13.5 million in 2019, then tumbled by 53.68% to $6.3 million in 2020, then tumbled by 98.05% to $121818.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Treasury Shares are $121818.0 (Q4 2021), $2.4 million (Q3 2021), and $2.4 million (Q2 2021).